Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

Price history

Latigo Biotherapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-27.07%

Period high

$25.00

Period low

$12.60

Latest

$13.31

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 13, 2026Nov 13, 2026
SC 13G/ANov 6, 2026Nov 6, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
SC 13GOct 29, 2026Oct 29, 2026
10-QSep 3, 2026Sep 3, 2026
8-KSep 3, 2026Sep 3, 2026
SC 13GAug 18, 2026Aug 18, 2026
SC 13DAug 17, 2026Aug 17, 2026
SC 13GAug 17, 2026Aug 17, 2026
SC 13GAug 13, 2026Aug 13, 2026
4Aug 12, 2026Aug 12, 2026
4Aug 12, 2026Aug 12, 2026
3Aug 12, 2026Aug 12, 2026
4Aug 11, 2026Aug 11, 2026

Competitors

Who does Latigo Biotherapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about LTGO's filings, answered from its disclosures.

What is the latest LTGO filing?

The latest filing shown is SC 13G dated Nov 13, 2026.

How many recent filings does LTGO have?

Intrinsic Alpha currently shows 20 recent filings for LTGO.